Economic Impact of Bladder Cancer in the USA.

Otávio ClarkTulio SarmentoAnthony EcclestonJulia BrinkmannRenato PicoliVamsi DaliparthiJorine VossSanjana ChandrasekarAllison ThompsonJane Chang

Published in: PharmacoEconomics - open (2024)

Treatment and resource costs increase for bladder cancer as the disease recurs/progresses. More effective treatments that can delay recurrence/progression may reduce the economic burden associated with bladder cancer.

Keyphrases

muscle invasive bladder cancer
combination therapy